Protein will cause an insulin response, which is why waiting is so crucial, but after the window, its perfectly fine
Tirzepatide (a dual GIP/GLP-1 agonist) showed positive Phase 2 results for MASH in the SYNERGY-NASH trial
Together, they hit GH production from two angles simultaneously, generating a stronger and more sustained pulse than either peptide produces alone
They have been in the market since the 1940s and, by 2017, their global market was valued at more than USD 130 billion [79]
More significant changes, such as improvements in body composition and muscle tone, typically become more apparent after two to three months of consistent use
It follows with increased melanin production that leads to hyperpigmentation and reduced effect of glutathione